CAS 154229-19-3
:Abiraterone
- (3Beta)-17-(Pyridin-3-Yl)Androsta-5,16-Dien-3-Ol
- (3b)-17-(3-pyridinyl)-Androsta-5,16-dien-3-ol
- 17-(3-Pyridinyl)-androsta-5,16-dien-3β-ol
- 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol
- Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3β)-
- Cb 7598
- Abiraterone
Abiraterone
CAS:Formula:C24H31NOPurezza:>98.0%(HPLC)Colore e forma:White to Almost white powder to crystalPeso molecolare:349.52Abiraterone
CAS:Abiraterone (CB-7598) (CB-7598) is an effective steroidal cytochrome P450 17alpha-hydroxylase-17, 20-lyase (CYP17) inhibitor (IC50: 4 nM).Formula:C24H31NOPurezza:99.18% - 99.93%Colore e forma:White SolidPeso molecolare:349.51(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol
CAS:Formula:C24H31NOPurezza:99%Colore e forma:SolidPeso molecolare:349.5090Abiraterone Sulfate Sodium Salt
CAS:Stability Hygroscopic
Applications Abiraterone Sulfate is an analogue of Abiraterone (A108490).Formula:C24H30NO4S·NaColore e forma:NeatPeso molecolare:451.55Abiraterone
CAS:Prodotto controllatoApplications Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.
References Denis, L., et al.: Cancer, 72, 3888 (1993); Potter, G.A., et al.: J. Med. Chem., 38, 2463 (1995); Denmeade, S., et al.: Nat. Rev., 2, 389 (2002); Scher, H., et al.: J. Clin. Oncol., 23, 8253 (2005);Formula:C24H31NOColore e forma:WhitePeso molecolare:349.51Abiraterone N-Oxide Sulfate Sodium Salt
CAS:Applications Abiraterone N-Oxide Sulfate is an analogue of Abiraterone (A108490).
Formula:C24H30NO5S·NaColore e forma:NeatPeso molecolare:467.5535(3-β)-17-(3-Pyridinyl)-androsta-5,16-dien-3-ol
CAS:Formula:C24H31NOPurezza:99%Colore e forma:SolidPeso molecolare:349.518Abiraterone - Bio-X ™
CAS:Prodotto controllatoAbiraterone is an anti-cancer drug that has been shown to be effective in treating prostate cancer. It works by blocking the production of testosterone by inhibiting androgen synthesis. Abiraterone does this by inhibiting CYP17A1, which converts cholesterol into pregnenolone, and then into progesterone and testosterone. Furthermore, it binds to the enzyme steroid 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). Abiraterone is usually a last resort for patients who have stopped responding to other lines of hormone therapies, which is known as second-line therapy.
Formula:C24H31NOPurezza:Min. 95%Colore e forma:PowderPeso molecolare:349.51 g/molAbiraterone
CAS:Prodotto controllatoCYP17 enzyme inhibitor
Formula:C24H31NOPurezza:Min. 95%Colore e forma:White PowderPeso molecolare:349.51 g/mol









